Risk factors of acute renal impairment after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

This publication has 23 references indexed in Scilit:

• Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
  Annals of Surgical Oncology, 2014
• The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery
  Renal Failure, 2014
• Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Overview and rationale
  European Journal of Surgical Oncology, 2013
• Consensus Guidelines from The American Society of Peritoneal Surface Malignancies on Standardizing the Delivery of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Patients in the United States
  Annals of Surgical Oncology, 2013
• The role of hyperosmotic stress in inflammation and disease
  BioMolecular Concepts, 2012
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
  Annals of Surgical Oncology, 2011
• Adriamycin nephropathy: A model of focal segmental glomerulosclerosis
  Nephrology, 2010
• Mechanisms of Cisplatin Nephrotoxicity
  Toxins, 2010
• Severe Electrolyte Disturbances After Hyperthermic Intraperitoneal Chemotherapy: Oxaliplatin Versus Mitomycin C
  Annals of Surgical Oncology, 2010
• Glucotoxicity in Peritoneal Dialysis—Solutions for the Solution!
  Advances in Chronic Kidney Disease, 2007